Lanean...
Novel therapies for severe asthma in children and adults
The heterogeneous nature of asthma requires personalised treatments. Monoclonal antibody treatments showed good efficacy, and should be considered when symptoms are poorly controlled despite good inhaler technique, compliance and controlled comorbidities. http://ow.ly/UWpg30hImQh
Gorde:
| Argitaratua izan da: | Breathe (Sheff) |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
European Respiratory Society
2018
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5831346/ https://ncbi.nlm.nih.gov/pubmed/29515670 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/20734735.018917 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|